Drug Free Solution Inc

Drug Free Solution Inc has a capital structure characterized by a total equity of $20,030,000 and no long-term debt, resulting in a debt-to-equity ratio of 0.0. The company's liquidity position is assessed as low, with an operating cash flow of -$625,330,000, indicating significant cash outflows from operations. This is further exacerbated by a negative return on equity of -0.8597, suggesting poor capital efficiency and profitability. Profitability metrics show that the company is currently unprofitable, with an operating income and net income of -$17,220,000. These figures are below the industry median for profitability metrics, indicating that the company is underperforming relative to its peers in the Healthcare Facilities & Services industry. The company's revenue concentration and geographic exposure are not explicitly detailed in the available data, but the absence of disclosed segments suggests a lack of diversification in its business operations. This could pose a risk if the company's primary market or product line experiences a downturn. The company's growth trajectory is uncertain, as there are no specific numeric deltas provided for the current or next fiscal year. However, the significant negative operating cash flow and net loss suggest that the company is not currently generating positive returns or experiencing growth. The absence of capital expenditures beyond -$4,870,000 also indicates limited investment in future growth. Risk factors for Drug Free Solution Inc include a low liquidity position and the potential for dilution, although the risk of dilution is currently assessed as low. The company has no immediate filing-based liquidity or dilution flags, but the negative operating cash flow and net loss could signal underlying financial stress. No adjustments have been applied to the valuation metrics, indicating that the reported figures are unadjusted. Recent events and filings do not show any significant developments that would impact the company's financial position or strategic direction. The absence of disclosed events or transcripts suggests a lack of recent material activity or communication from the company.